达可替尼治疗肺腺癌出现甲横沟和尿酸升高1例
A Case of Nail Transverse Groove and Elevated Uric Acid in Lung Adenocarcinoma Treated with Dacomitinib
DOI: 10.12677/ACM.2023.1351041, PDF,   
作者: 张又红*：湖南中医药大学研究生院，湖南 长沙；王桂华#：长沙市中心医院肿瘤科，湖南 长沙
关键词: 达可替尼；肺腺癌；甲横沟；尿酸；Dacomitinib； Lung Adenocarcinoma； Transverse Nail Sulcus； Uric Acid
摘要: 目的：报道1例达可替尼治疗肺腺癌后出现甲横沟和尿酸升高。方法：描述1名90岁的肺腺癌晚期患者经基因检测提示EGFR 21号外显子突变，予以达可替尼靶向治疗后出现副反应。结果：达可替尼靶向治疗1月后出现口腔溃疡、腹泻、手指和脚趾开裂并疼痛，复查实验室检查异常的有血红蛋白、淋巴细胞绝对值、白蛋白、钙、癌胚抗原较基线资料下降，尿酸较前升高。双手手指出现甲横沟。结论：密切观察达可替尼治疗肺腺癌的副反应，及时调整治疗方案。
Abstract: Objective: To report for the first time a case of elevated nail transverse groove and uric acid after dacomitinib treatment for lung adenocarcinoma. Methods: A 90-year-old patient with advanced lung adenocarcinoma with genetic testing suggesting EGFR21 exon mutation developed side effects after targeted treatment with dacomitinib. Results: After 1 month of dacomitinib-targeted therapy, he developed oral ulcers, diarrhea, cracked and painful fingers and toes, and abnormal laboratory tests on review included decreased hemoglobin, absolute lymphocyte values, albumin, calcium, and carcinoembryonic antigen compared with baseline data, and increased uric acid compared with previous data. Transverse nail grooves appeared in the fingers of both hands. Conclusion: The side effects of dacomitinib for lung adenocarcinoma should be closely observed and the treatment regi-men should be adjusted in a timely manner.
文章引用：张又红, 王桂华. 达可替尼治疗肺腺癌出现甲横沟和尿酸升高1例[J]. 临床医学进展, 2023, 13(5): 7461-7465. https://doi.org/10.12677/ACM.2023.1351041

参考文献

[1] 曹毛毛, 陈万青. 中国恶性肿瘤流行情况及防控现状[J]. 中国肿瘤临床, 2019, 46(3): 145-149.
[2] Miller, K.D., Siegel, R.L., Lin, C.C., et al. (2016) Cancer Treatment and Survivorship Statistics, 2016. CA: A Cancer Journal for Cli-nicians, 66, 271-289. [Google Scholar] [CrossRef] [PubMed]
[3] Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. [Google Scholar] [CrossRef] [PubMed]
[4] Kris, M.G., Johnson, B.E., Berry, L.D., et al. (2014) Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs. JAMA, 311, 1998-2006. [Google Scholar] [CrossRef] [PubMed]
[5] Papadimitrakopoulou, V.A., Mok, T.S., Han, J.Y., et al. (2020) Osi-mertinib versus Platinum-Pemetrexed for Patients with EGFR T790M Advanced NSCLC and Progression on a Prior EGFR-Tyrosine Kinase Inhibitor: AURA3 Overall Survival Analysis. Annals of Oncology, 31, 1536-1544. [Google Scholar] [CrossRef] [PubMed]
[6] 姬巧霞, 张红斌, 王愿, 赵敏. 晚期非小细胞肺癌患者表皮生长因子受体基因突变的危险因素及表皮生长因子受体酪氨酸激酶抑制剂的疗效分析[J]. 中国医药, 2023, 18(2): 211-215.
[7] Bach, D.H., Kim, D., Bae, S.Y., et al. (2018) Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells. Molecular Therapy Nucleic Acids, 11, 455-467. [Google Scholar] [CrossRef] [PubMed]
[8] Mok, T.S., Cheng, Y., Zhou, X., et al. (2018) Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib with Gefitinib in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations. Journal of Clinical Oncology, 36, 2244-2250. [Google Scholar] [CrossRef] 
[9] Sabbah, D.A., Hajjo, R. and Sweidan, K. (2020) Review on Epi-dermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR In-hibitors. Current Topics in Medicinal Chemistry, 20, 815-834. [Google Scholar] [CrossRef] [PubMed]
[10] Ben-Dayan, D., Mittelman, M., Floru, S., et al. (1994) Transverse Nail Ridgings (Beau’s Lines) Induced by Chemotherapy. Acta Haematologica, 91, 89-90. [Google Scholar] [CrossRef] [PubMed]
[11] Ermertcan, A.T., Yaşar, A., Kayhan, T., et al. (2011) Hypohidrotic Ecto-dermal Dysplasia Associated with Glucose-6-Phosphate Dehydrogenase Deficiency. Annals of Dermatology, 23, S8-s10. [Google Scholar] [CrossRef] 
[12] Tucker, W.F. and Church, R.E. (1984) Beau’s Lines after Razoxane Therapy for Psoriasis. Archives of Dermatology, 120, 1140. [Google Scholar] [CrossRef] [PubMed]
[13] Patki, A.H. and Mehta, J.M. (1989) Dap-sone-Induced Erythroderma with Beau’s Lines. Leprosy Review, 60, 274-277. [Google Scholar] [CrossRef] [PubMed]
[14] Hood, A.F. (1986) Cutaneous Side Effects of Cancer Chemo-therapy. Medical Clinics of North America, 70, 187-209. [Google Scholar] [CrossRef] 
[15] Requena, L. (1991) Chemotherapy-Induced Transverse Ridging of the Nails. Cutis, 48, 129-130.

为你推荐